Novartis Ag (NVS) Other Working Capital Changes (2022 - 2026)

Novartis Ag's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at $346.0 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 181.6% year-over-year to $346.0 million; the TTM figure through Mar 2026 stood at -$147.0 million (up 82.1% YoY), while the FY2025 annual figure was -$461.0 million, changed N/A from the prior year.
• Other Working Capital Changes came in at $346.0 million for Q1 2026 at Novartis Ag, up from -$461.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $392.0 million in Q3 2025 to a low of -$461.0 million in Q4 2025.
• A 5-year average of -$79.9 million and a median of -$79.5 million in 2022 frame the typical range for Other Working Capital Changes.
• On a YoY basis, Other Working Capital Changes climbed as much as 853.85% in 2025 and fell as far as 531.51% in 2025.
• Novartis Ag's Other Working Capital Changes stood at -$86.0 million in 2022, then soared by 118.6% to $16.0 million in 2023, then tumbled by 556.25% to -$73.0 million in 2024, then plunged by 531.51% to -$461.0 million in 2025, then jumped by 175.05% to $346.0 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $346.0 million, -$461.0 million, and $392.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison